Exploration of Immune-Modulatory Effects of Amivantamab in Combination with Pembrolizumab in Lung and Head and Neck Squamous Cell Carcinoma.
Lim SM, Kang SS, Kim DK, Lee SH, Synn CB, Baek S, Yang SM, Han YJ, Kim MH, Han H, Na K, Kim YT, Yun MR, Kim JH, Byeon Y, Kim YS, Lee JB, Hong MH, Curtin JC, Patel B, Bergiers I, Pyo KH, Cho BC.
Lim SM, et al. Among authors: kang ss.
Cancer Res Commun. 2024 Jul 1;4(7):1748-1764. doi: 10.1158/2767-9764.CRC-24-0107.
Cancer Res Commun. 2024.
PMID: 38916448
Free PMC article.